Conversion Consideration. (i) Generally. Subject to Section 5.03(A)(ii) and Section 5.03(A)(iv), the type and amount of consideration (the “Conversion Consideration”) due in respect of each $1,000 Capitalized Principal Amount of a Note to be converted will be: (1) a number of shares of Common Stock equal to the Conversion Rate for such conversion; plus (2) the Applicable Premium or, if applicable, the Strategic Make-Whole (but, for the avoidance of doubt, Holders shall not be entitled to receive both the Applicable Premium and Strategic Make-Whole with respect to any conversion);
Appears in 2 contracts
Sources: Indenture (Biora Therapeutics, Inc.), Indenture (Biora Therapeutics, Inc.)